-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The tide of integration of global agrochemical groups may usher in a new case of acquisition by a giant company.
According to the latest news from the Bayer Group’s official website, the US seed giant Monsanto (105.
2, -0.
49, -0.
46%) announced at the Monsanto shareholders’ special meeting held on December 13 that the company’s shareholders approved Monsanto and a wholly-owned subsidiary of Bayer Co.
, Ltd.
Merger of subsidiaries.
According to the M&A agreement, Monsanto shareholders will receive US$128 in cash per share at the time of closing of the merger, with a total transaction value of US$66 billion.
Bayer is a leading global biopharmaceutical company headquartered in Germany.
Once the acquisition is completed, the new enterprise will become the world's largest supplier of genetically modified seeds and agrochemical manufacturers.
The acquisition will also become the largest overseas investment by a German company to date.
With the support of Monsanto, Bayer has now submitted various filing documents.
The delivery is expected to be completed by the end of 2017.
"We firmly believe that this merger can help solve the increasingly difficult challenges facing growers and the agricultural industry now and in the future.
This is the motivation for us to acquire Monsanto.
" Bayer CEO Werner Baumann said, " We look forward to completing the transaction and working closely with Monsanto to ensure successful integration.
” Since 2015, the integration of the global agrochemical industry has accelerated.
In December 2015, DuPont and Dow merged.
In February 2016, ChemChina announced the acquisition of Swiss agrochemical company Syngenta (79.
32, -0.
21, -0.
26%) for USD 43 billion.
According to the latest news from the Bayer Group’s official website, the US seed giant Monsanto (105.
2, -0.
49, -0.
46%) announced at the Monsanto shareholders’ special meeting held on December 13 that the company’s shareholders approved Monsanto and a wholly-owned subsidiary of Bayer Co.
, Ltd.
Merger of subsidiaries.
According to the M&A agreement, Monsanto shareholders will receive US$128 in cash per share at the time of closing of the merger, with a total transaction value of US$66 billion.
Bayer is a leading global biopharmaceutical company headquartered in Germany.
Once the acquisition is completed, the new enterprise will become the world's largest supplier of genetically modified seeds and agrochemical manufacturers.
The acquisition will also become the largest overseas investment by a German company to date.
With the support of Monsanto, Bayer has now submitted various filing documents.
The delivery is expected to be completed by the end of 2017.
"We firmly believe that this merger can help solve the increasingly difficult challenges facing growers and the agricultural industry now and in the future.
This is the motivation for us to acquire Monsanto.
" Bayer CEO Werner Baumann said, " We look forward to completing the transaction and working closely with Monsanto to ensure successful integration.
” Since 2015, the integration of the global agrochemical industry has accelerated.
In December 2015, DuPont and Dow merged.
In February 2016, ChemChina announced the acquisition of Swiss agrochemical company Syngenta (79.
32, -0.
21, -0.
26%) for USD 43 billion.
